Brigham Buhler

But when the FDA allows opioids to be rammed into the marketplace, because the head of the FDA went to go work for Purdue Pharma 18 months later after giving them the goose that laid the golden egg, a label that says these are non-addictive, non-abusive, when they never had a human safety study on that. How? How can they do that? They daisy chain this drug into the marketplace.

But when the FDA allows opioids to be rammed into the marketplace, because the head of the FDA went to go work for Purdue Pharma 18 months later after giving them the goose that laid the golden egg, a label that says these are non-addictive, non-abusive, when they never had a human safety study on that. How? How can they do that? They daisy chain this drug into the marketplace.

But when the FDA allows opioids to be rammed into the marketplace, because the head of the FDA went to go work for Purdue Pharma 18 months later after giving them the goose that laid the golden egg, a label that says these are non-addictive, non-abusive, when they never had a human safety study on that. How? How can they do that? They daisy chain this drug into the marketplace.

It's a lot to digest. So sorry, I'm trying to explain it very complex. I don't know how I missed the fact that the head of the FDA went to work for Purdue Pharma. 18 months later, it took a big salary job. And I think in the last 40 years, only two heads of the FDA haven't gone to work for industry.

It's a lot to digest. So sorry, I'm trying to explain it very complex. I don't know how I missed the fact that the head of the FDA went to work for Purdue Pharma. 18 months later, it took a big salary job. And I think in the last 40 years, only two heads of the FDA haven't gone to work for industry.

It's a lot to digest. So sorry, I'm trying to explain it very complex. I don't know how I missed the fact that the head of the FDA went to work for Purdue Pharma. 18 months later, it took a big salary job. And I think in the last 40 years, only two heads of the FDA haven't gone to work for industry.

Oxycontin.

Oxycontin.

Oxycontin.

And what happened is what happens so often in big pharma. When they say pharmaceutical companies innovate and that's why they make all this money. Okay. The United States pays for roughly, makes up 60% of the pharmaceuticals industry's profitability. But we're ranked 40th overall in healthcare outcomes. 40th. We have a train wreck healthcare system.

And what happened is what happens so often in big pharma. When they say pharmaceutical companies innovate and that's why they make all this money. Okay. The United States pays for roughly, makes up 60% of the pharmaceuticals industry's profitability. But we're ranked 40th overall in healthcare outcomes. 40th. We have a train wreck healthcare system.

And what happened is what happens so often in big pharma. When they say pharmaceutical companies innovate and that's why they make all this money. Okay. The United States pays for roughly, makes up 60% of the pharmaceuticals industry's profitability. But we're ranked 40th overall in healthcare outcomes. 40th. We have a train wreck healthcare system.

Again, four or more drugs the average American's on. The pharmaceutical companies are not fitting the bill for the research and development. We, the taxpayers, are because we fund the NIH and the NIH does most of the early product development. Then they sell the patent to the pharmaceutical companies for pennies on the dollar.

Again, four or more drugs the average American's on. The pharmaceutical companies are not fitting the bill for the research and development. We, the taxpayers, are because we fund the NIH and the NIH does most of the early product development. Then they sell the patent to the pharmaceutical companies for pennies on the dollar.

Again, four or more drugs the average American's on. The pharmaceutical companies are not fitting the bill for the research and development. We, the taxpayers, are because we fund the NIH and the NIH does most of the early product development. Then they sell the patent to the pharmaceutical companies for pennies on the dollar.

Pharmaceutical companies pick them up and use their relationship and lobbying power with the FDA to bring these products to market. Okay, so there's that.

Pharmaceutical companies pick them up and use their relationship and lobbying power with the FDA to bring these products to market. Okay, so there's that.

Pharmaceutical companies pick them up and use their relationship and lobbying power with the FDA to bring these products to market. Okay, so there's that.

The other thing that pharmaceutical companies do that is not innovative and in a way to extend their revenue streams and maximize profits is they refile patents by changing subtleties of molecules or delivery mechanisms and they get additional patents that make it impossible for a competitor to come into the marketplace. That's exactly what happened with Purdue Pharma.

The other thing that pharmaceutical companies do that is not innovative and in a way to extend their revenue streams and maximize profits is they refile patents by changing subtleties of molecules or delivery mechanisms and they get additional patents that make it impossible for a competitor to come into the marketplace. That's exactly what happened with Purdue Pharma.